ATE272052T1 - Thioharnstoff-inhibitoren von herpes-virus - Google Patents

Thioharnstoff-inhibitoren von herpes-virus

Info

Publication number
ATE272052T1
ATE272052T1 AT99963021T AT99963021T ATE272052T1 AT E272052 T1 ATE272052 T1 AT E272052T1 AT 99963021 T AT99963021 T AT 99963021T AT 99963021 T AT99963021 T AT 99963021T AT E272052 T1 ATE272052 T1 AT E272052T1
Authority
AT
Austria
Prior art keywords
herpes virus
thiourea inhibitors
thiourea
inhibitors
herpes
Prior art date
Application number
AT99963021T
Other languages
English (en)
Inventor
Jonathan David Bloom
Kevin Joseph Curran
Martin Joseph Digrandi
Russell George Dushin
Stanley Albert Lang
Emily Boucher Norton
Adma Antonia Ross
Bryan Mark O'hara
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE272052T1 publication Critical patent/ATE272052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99963021T 1998-12-09 1999-12-06 Thioharnstoff-inhibitoren von herpes-virus ATE272052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20856198A 1998-12-09 1998-12-09
PCT/US1999/028837 WO2000034238A1 (en) 1998-12-09 1999-12-06 Thiourea inhibitors of herpes viruses

Publications (1)

Publication Number Publication Date
ATE272052T1 true ATE272052T1 (de) 2004-08-15

Family

ID=22775050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99963021T ATE272052T1 (de) 1998-12-09 1999-12-06 Thioharnstoff-inhibitoren von herpes-virus

Country Status (26)

Country Link
EP (1) EP1137632B1 (de)
JP (1) JP2002531545A (de)
KR (1) KR20010089559A (de)
CN (1) CN1332725A (de)
AR (1) AR033789A1 (de)
AT (1) ATE272052T1 (de)
AU (1) AU1934500A (de)
BG (1) BG105583A (de)
BR (1) BR9916086A (de)
CA (1) CA2351403A1 (de)
CZ (1) CZ20011957A3 (de)
DE (1) DE69919023T2 (de)
DK (1) DK1137632T3 (de)
EA (1) EA200100634A1 (de)
ES (1) ES2224733T3 (de)
HU (1) HUP0104763A3 (de)
ID (1) ID30287A (de)
IL (1) IL143262A0 (de)
NO (1) NO20012838L (de)
NZ (1) NZ512108A (de)
PL (1) PL348178A1 (de)
PT (1) PT1137632E (de)
SK (1) SK7702001A3 (de)
TR (1) TR200101597T2 (de)
WO (1) WO2000034238A1 (de)
ZA (1) ZA200104144B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
WO2001064642A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
DE10217518A1 (de) * 2002-04-19 2003-11-06 Bayer Ag Lactone
DE10222024A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Lactame
DE10257786A1 (de) * 2002-12-11 2004-07-01 Bayer Healthcare Ag Oxazolidinone
EP2077995B1 (de) 2006-11-02 2012-02-08 Millennium Pharmaceuticals, Inc. Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer
CN103717757A (zh) 2011-05-24 2014-04-09 威斯特研究所 用于调节爱泼斯坦-巴尔核抗原1的活性的组合物和方法
EP2914592B1 (de) 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitoren des cytomegalovirus
US9284310B2 (en) 2012-11-03 2016-03-15 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
WO2023036140A1 (zh) * 2021-09-07 2023-03-16 上海齐鲁制药研究中心有限公司 3CLpro蛋白酶抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
PL192628B1 (pl) * 1996-04-23 2006-11-30 Vertex Pharma Pochodne mocznika, kompozycje farmaceutyczne i zastosowanie związku i kompozycji

Also Published As

Publication number Publication date
AR033789A1 (es) 2004-01-07
ES2224733T3 (es) 2005-03-01
DE69919023T2 (de) 2005-07-28
CZ20011957A3 (cs) 2001-10-17
SK7702001A3 (en) 2002-04-04
TR200101597T2 (tr) 2001-10-22
JP2002531545A (ja) 2002-09-24
DE69919023D1 (de) 2004-09-02
BG105583A (en) 2001-12-29
EP1137632A1 (de) 2001-10-04
CA2351403A1 (en) 2000-06-15
NZ512108A (en) 2003-09-26
HUP0104763A2 (hu) 2002-04-29
PL348178A1 (en) 2002-05-06
NO20012838D0 (no) 2001-06-08
NO20012838L (no) 2001-08-08
WO2000034238A1 (en) 2000-06-15
EA200100634A1 (ru) 2001-10-22
PT1137632E (pt) 2004-11-30
HUP0104763A3 (en) 2005-04-28
BR9916086A (pt) 2001-09-04
AU1934500A (en) 2000-06-26
EP1137632B1 (de) 2004-07-28
ID30287A (id) 2001-11-15
CN1332725A (zh) 2002-01-23
IL143262A0 (en) 2002-04-21
DK1137632T3 (da) 2004-11-01
KR20010089559A (ko) 2001-10-06
ZA200104144B (en) 2002-08-21

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69941116D1 (de) G von gdf-8
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DK1117669T3 (da) Antiviruspurinderivater
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO20012834D0 (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
DK1137632T3 (da) Thiourinstofinhibitorer af herpesvira
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20012836D0 (no) Tiourea-inhibitorer for herpes virus
NO20012835D0 (no) Heterocykliske karboksamid-holdige tiourea-inhibitorer for herpesvirus inneholdende en substituert fenylendiamingruppe
NO20012837D0 (no) Tiourea-inhibitorer for herpesvirus
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE69811256D1 (de) Polymorphe modifikationen von dofetilid
DE69927626D1 (de) Ausführung von Permutationen
DK1137645T3 (da) Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe
DE69930014D1 (de) Wirksame verarbeitung von mehrfachverbindungsverkehr
DE69918081D1 (de) Reinigung von pentafluorophenyl borverbindungen
DE69803309D1 (de) Rückgewinnung von gipsmaterialien
IT1296764B1 (it) Movimentazione di piastrelle.
UA2U (uk) Конструкція накладної кишені
HK1037373A (en) Thiourea inhibitors of herpes viruses
UA2298S (uk) Комплект плиток облицювальних
IT1294703B1 (it) Struttura di acquario o acquaterrario
IT238070Y1 (it) Raggruppatore-sostegno di recipienti
FI982552A0 (fi) Stabilointimenetelmä

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137632

Country of ref document: EP

REN Ceased due to non-payment of the annual fee